Antongiulio F.
- Country
- Italy
- Department
- Oncology
Research Overview
Data & Insights
Has run more than one trial at 0 of 26 partner sites.
Specializations
Hematologic Oncology
Investigator Antongiulio Faggiano focuses on malignant blood disorders, addressing both acute and chronic disease phenotypes.
- Acute Myeloid Leukemia with FLT3 mutation
- Chronic Myeloid Leukemia in chronic phase
- Relapsed or Refractory Multiple Myeloma
- Early‑stage Follicular Lymphoma
- Myelodysplastic Syndromes
Therapeutic efforts emphasize targeted agents, cellular therapies, and strategies to improve remission durability.
Solid Tumor Oncology
His work encompasses a broad spectrum of epithelial cancers, integrating systemic and localized treatment modalities.
- Breast Cancer
- Prostate Cancer (high‑risk localized and metastatic)
- Gastroenteropancreatic Neuroendocrine Tumors
- Non‑muscle invasive Bladder Cancer
- Transthyretin‑Mediated Amyloid Cardiomyopathy
Research targets novel biologics, radioligand therapy, and precision‑medicine approaches.
Neuromuscular and Autoimmune Disorders
He investigates immune‑mediated neuromuscular diseases, aiming to modulate pathogenic pathways.
- Generalized Myasthenia Gravis
- Chronic Inflammatory Demyelinating Polyneuropathy
- Idiopathic Inflammatory Myopathy
- Facioscapulohumeral Muscular Dystrophy
- Multiple Sclerosis (relapsing‑remitting and progressive)
Therapeutic focus includes monoclonal antibodies, complement inhibition, and disease‑modifying agents.
Cardiovascular and Metabolic Medicine
His portfolio addresses major cardiac and metabolic risk factors, emphasizing outcome‑driven interventions.
- Atrial Fibrillation
- Heart Failure (HFpEF/HFmrEF)
- Hypertension (uncontrolled and resistant)
- Hypercholesterolemia
- Transthyretin Amyloid Cardiomyopathy
Efforts prioritize anti‑inflammatory strategies, lipid‑lowering biologics, and novel cardiac myosin inhibitors.
Pulmonary and Respiratory Medicine
He contributes to the management of chronic lung diseases, targeting inflammation and fibrosis.
- Chronic Obstructive Pulmonary Disease
- Idiopathic Pulmonary Fibrosis
- Uncontrolled Moderate to Severe Eosinophilic Asthma
- Bronchiectasis
- Progressive Pulmonary Fibrosis
Research explores anti‑fibrotic agents, biologic pathways, and combination inhaled therapies.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.